At a glance
- Originator GlaxoSmithKline
- Class Antipsychotics; Benzamides
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 24 Aug 1999 Discontinued-I for Schizophrenia in USA (Unknown route)
- 05 Jul 1999 No-Development-Reported for Schizophrenia in USA (Unknown route)
- 26 May 1997 New profile